Exogen (US) prepares for European launch of sonic fracture healing
This article was originally published in Clinica
Exogen (US) is gearing up for the European launch of its sonic accelerated fracture healing process scheduled for the beginning of next year. The company has set up a European subsidiary in Diessen, near Munich, in Germany and has completed distribution agreements in Italy, France, the Netherlands and the UK. The Exogen system received US FDA clearance last year and has gained favourable assessments for reimbursement from Blue Cross/Blue Shield (see Clinica No 668, p 20).